×
About 196,693 results

Advice from the Trenches on Type 2 Diabetes Care
https://www.mdedge.com/type-2-diabetes-icymi/article/254237/diabetes/advice-trenches-type-2-diabetes-care
Davida F. Kruger, MSN, APRN-BC, BC-ADM

May 23rd, 2022 - Davida F. Kruger, MSN, APN-BC, BC-ADM Ms.

Low glycemic index diet helps heart patients lose weight
https://www.eurekalert.org/news-releases/953310

May 23rd, 2022 - Madrid, Spain – 23 May 2022: Eating low glycaemic index foods promotes a healthier body shape in patients with coronary artery disease, according to a study presented at ACNAP-EuroHeartCare Congress 2022, a scientific congress of the European Society of Cardiology (ESC).1 The glycaemic index (GI) ranks carbohydrate-containing foods according to how quickly they affect blood sugar levels. High G...

Alcohol may be more risky to the heart than previously thought
https://www.eurekalert.org/news-releases/953314

May 22nd, 2022 - Madrid, Spain – 22 May 2022: Levels of alcohol consumption currently considered safe by some countries are linked with development of heart failure, according to research presented at Heart Failure 2022, a scientific congress of the European Society of Cardiology (ESC).1 “This study adds to the body of evidence that a more cautious approach to alcohol consumption is needed,” said study author D...

CRC Screening: Blood Test Accuracy Compared to Colonoscopy
https://www.medscape.com/viewarticle/974402

May 21st, 2022 - The first prospective study to evaluate the accuracy of a blood test for people being screened for colorectal cancer (CRC) revealed a high sensitivity and specificity. At 90% specificity, the blood assay (Guardant Health) was 100% sensitive for detecting CRC. At 95% specificity, sensitivity was 88%. The blood assay detects circulating tumor DNA from cancer in the bloodstream, which is then anal...

Gender Affirming Hormone Therapy has a positive impact on well-being
https://www.eurekalert.org/news-releases/953439

May 21st, 2022 - New evidence shows that people who have undergone Gender Affirming Hormone Therapy report high grades of satisfaction with both the physical and psychological effects. A new study on this topic, carried out by researchers in Portugal, will be presented today (21 May 2022) at the 24th European Congress of Endocrinology in Milan, Italy. Gender Affirming Hormone Therapy (GAHT) aims to align the ch...

20th anniversary and history of cosmetic botulinum toxin type A
https://www.mdedge.com/dermatology/article/254808/aesthetic-dermatology/20th-anniversary-and-history-cosmetic-botulinum
Naissan O. Wesley, MD

May 20th, 2022 - Historical food-borne outbreaks of botulism and identification of Clostridium botulinum as the bacterium responsible have had an enormous impact in medicine related to its therapeutic and cosmetic uses. The timeline of botulinum toxin discovery began with deadly outbreaks related to contaminated food across Europe in the late 1700s, the largest of which occurred in 1793 in Wildebrad, in souther.

FAQs on Philips Respironics Ventilator, BiPAP Machine, and CPAP Machine Recalls
https://www.fda.gov/medical-devices/safety-communications/faqs-philips-respironics-ventilator-bipap-machine-and-cpap-machine-recalls
MedWatch; FDA

May 20th, 2022 - UPDATE: On May 19, 2022, the FDA updated this web page to help ensure patients and providers have important information about the recall of these critical devices. See What the FDA is Doing for more information. Philips Respironics (Philips) voluntarily recalled certain ventilators, bi-level positive airway pressure (also known as Bilevel PAP, BiPAP, or BPAP) machines, and continuous positive a...

Trending Clinical Topic: Periodontal Disease
https://reference.medscape.com/viewarticle/973638

May 20th, 2022 - Each week, we identify one top search term, speculate about what caused its popularity, and provide an infographic on a related condition. If you have thoughts about what's trending and why, share them with us on Twitter or Facebook.  The association between gum disease and significant comorbidities has been highlighted in several recent studies. From inflammatory disorders to neurologic disord...

PROGRESS-CTO: International chronic total occlusion percutaneous coronary intervention registry finds increasing procedural success
https://www.eurekalert.org/news-releases/953213

May 20th, 2022 - ATLANTA, GA (May 20, 2022) – A new analysis of PROGRESS-CTO (PROspective Global REgiStry for the Study of Chronic Total Occlusion Intervention; www.progresscto.org), an international multi-center registry of chronic total occlusion (CTO) percutaneous coronary intervention (PCI), was presented today as late-breaking clinical research at the Society for Cardiovascular Angiography & Interventions ...

Long term use of clopidogrel monotherapy associated with lower patient risk compared to aspirin monotherapy
https://www.eurekalert.org/news-releases/953214

May 20th, 2022 - ATLANTA, GA (May 20, 2022) – Results from a real-world study investigating safety and effectiveness of clopidogrel versus aspirin monotherapy beyond 12 months after PCI in high-risk patients during the chronic maintenance period. This study found that clopidogrel monotherapy was associated with reduced risk of net adverse clinical events (NACE; all-cause death, MI, stent thrombosis, stroke, or ...

Peptide created by Brazilian group delays melanoma growth in animal trials
https://www.eurekalert.org/news-releases/953431

May 20th, 2022 - An article published in Scientific Reports describes a study demonstrating the effectiveness of a peptide developed by Brazilian scientists, called Rb4, to combat cancer progression in an animal model, especially malignant melanoma. The molecule holds promise for the treatment of drug-resistant tumors. Preclinical in vitro and in vivo trials indicated that Rb4 triggers necrosis in murine melano...

Haywire T cells attack protein in "bad" cholesterol
https://www.eurekalert.org/news-releases/953484

May 20th, 2022 - LA JOLLA, CA—Preventing atherosclerosis, the underlying cause of heart disease, means scientists need to understand how immune cells drive inflammation in the arteries. The challenge is that the T cells involved in atherosclerosis are very rare and extremely hard to find in the bloodstream. "This is a classic needle-in-the-haystack problem," says La Jolla Institute for Immunology (LJI) Professo...

No-implant interatrial shunt device to treat heart failure patients reveals promising multi-center clinical data
https://www.eurekalert.org/news-releases/953211

May 20th, 2022 - ATLANTA, GA (May 20, 2022) – Results from early clinical evaluation of the Alleviant System to treat heart failure patients with preserved and reduced ejection fraction (HFpEF and HFrEF) was presented today as late-breaking clinical research at the Society for Cardiovascular Angiography & Interventions (SCAI) 2022 Scientific Sessions. This multi-center evaluation across three trial programs (AL...

New long-term data of paclitaxel devices continues to show no increased mortality compared to non-drug coated devices
https://www.eurekalert.org/news-releases/953209

May 20th, 2022 - ATLANTA, GA (May 20, 2022) – New long-term data from the Safety Assessment of Femoropopliteal Endovascular Treatment With PAclitaxel-coated Devices (SAFE-PAD) study were presented today as late-breaking clinical research at the Society for Cardiovascular Angiography & Interventions (SCAI) 2022 Scientific Sessions. The analysis found no meaningful difference in survival between patients treated ...

Research sheds light on crimean-congo hemorrhagic fever disease process
https://www.eurekalert.org/news-releases/953497

May 20th, 2022 - Army scientists determined that the body’s own natural immune response contributes to disease severity in mice infected with Crimean-Congo hemorrhagic fever virus (CCHFV), which causes a widespread tick-borne viral infection in humans. Their work, published May 19, 2022 in PLoS Pathogens, provides a deeper understanding of how the virus causes disease and forms a basis for developing medical co...

New clues in fight against lethal bacteria
https://www.eurekalert.org/news-releases/953408

May 20th, 2022 - New research from The Australian National University (ANU) could lead to better treatment options for a rare but very lethal type of bacterial infection. Professor Si Ming Man and his team say their latest research focuses on the family of bacteria that causes things like gangrene, sepsis and tetanus. “While we understand a select few members of this family of bacteria, we were interested in wh...

Novel preclinical drug could have potential to combat depression, brain injury and cognitive disorders
https://www.eurekalert.org/news-releases/953457

May 20th, 2022 - BIRMINGHAM, Ala. – James Bibb, Ph.D., and colleagues have described a novel preclinical drug that could have the potential to combat depression, brain injury and diseases that impair cognition. The drug, which notably is brain-permeable, acts to inhibit the kinase enzyme Cdk5. Cdk5 is a crucial regulator of signaling in brain neurons. Over three decades of study, it has been implicated in neuro...

A Cup of Cranberries a Day Tied to Better Memory 
https://www.medscape.com/viewarticle/974349

May 20th, 2022 - For healthy middle-aged and older adults, adding cranberries to the diet may help improve memory and brain function, in addition to lowering LDL cholesterol, new research suggests. Results from a randomized, placebo-controlled trial of adults aged 50-80 years showed that consuming freeze-dried cranberry extract, which is equal to one cup of fresh cranberries, for 12 weeks was associated with im...

Erectile Dysfunction in Diabetes May Be Underestimated
https://www.medscape.com/viewarticle/974357

May 20th, 2022 - The chance of men developing erectile function disorders increases as they get older. Diabetes mellitus can increase the risk of erectile dysfunction further. In a study of 351 men who had recently received a diagnosis of diabetes mellitus, scientists from the German Diabetes Center (DDZ) in Düsseldorf found that erectile dysfunction also occurs in men who have just developed diabetes and that ...

Tirzepatide's Retail Price Set at About $12,666 Per Year
https://www.medscape.com/viewarticle/974390

May 20th, 2022 - Tirzepatide (Mounjaro) — the new twincretin approved by the US Food and Drug Administration (FDA) for glycemic control in patients with type 2 diabetes — was priced by Lilly, the company that will market the drug, at a list price of $974.33 for four weekly doses regardless of dose size, a cost that adds up to about $12,666 per year, according to a statement made on May 20 by a Lilly spokesperso...